GR3031720T3 - Monoclonal antibodies against receptor-induced binding sites. - Google Patents
Monoclonal antibodies against receptor-induced binding sites.Info
- Publication number
- GR3031720T3 GR3031720T3 GR990402812T GR990402812T GR3031720T3 GR 3031720 T3 GR3031720 T3 GR 3031720T3 GR 990402812 T GR990402812 T GR 990402812T GR 990402812 T GR990402812 T GR 990402812T GR 3031720 T3 GR3031720 T3 GR 3031720T3
- Authority
- GR
- Greece
- Prior art keywords
- receptor
- ribs
- ligand
- binding sites
- monoclonal antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
- G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/654,839 US5372933A (en) | 1988-10-03 | 1991-02-12 | Polypeptides that mimic receptor-induced binding sites, and methods of using same |
PCT/US1992/001163 WO1992014150A1 (en) | 1991-02-12 | 1992-02-12 | Monoclonal antibodies against receptor-induced binding sites |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3031720T3 true GR3031720T3 (en) | 2000-02-29 |
Family
ID=24626448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR990402812T GR3031720T3 (en) | 1991-02-12 | 1999-11-03 | Monoclonal antibodies against receptor-induced binding sites. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5372933A (el) |
EP (1) | EP0573545B1 (el) |
JP (2) | JP3315405B2 (el) |
AT (1) | ATE184019T1 (el) |
CA (1) | CA2103893A1 (el) |
DE (1) | DE69229911T2 (el) |
DK (1) | DK0573545T3 (el) |
ES (1) | ES2134799T3 (el) |
GR (1) | GR3031720T3 (el) |
IE (1) | IE920462A1 (el) |
PT (1) | PT100122B (el) |
WO (1) | WO1992014150A1 (el) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6051231A (en) * | 1988-09-01 | 2000-04-18 | Bayer Corporation | Antiviral methods and prepations |
US6143298A (en) * | 1988-09-01 | 2000-11-07 | Bayer Corporation | Soluble truncated forms of ICAM-1 |
US6514936B1 (en) | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
DE68929096T2 (de) | 1988-09-01 | 2000-05-11 | Bayer Corp., Pittsburgh | Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt |
US6130202A (en) * | 1990-07-20 | 2000-10-10 | Bayer Corporation | Antiviral methods |
US6107461A (en) * | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
ES2134762T3 (es) * | 1990-07-20 | 1999-10-16 | Bayer Ag | Formas multimericas de proteinas receptoras de rinovirus humanos. |
US5645815A (en) | 1991-02-08 | 1997-07-08 | Diatide, Inc. | Radiolabled compounds for thrombus imaging |
US5736122A (en) * | 1991-02-08 | 1998-04-07 | Diatide, Inc. | Technetium-99m labeled peptides for thrombus imaging |
DK0570493T3 (da) * | 1991-02-08 | 2000-06-26 | Diatide Inc | Technetium-99m-mærkede polypeptider til billeddannelse. |
US5968476A (en) * | 1992-05-21 | 1999-10-19 | Diatide, Inc. | Technetium-99m labeled peptides for thrombus imaging |
US6057287A (en) * | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
DE19620443C2 (de) | 1996-05-21 | 1998-09-17 | Rhein Biotech Proz & Prod Gmbh | Verfahren zum automatischen Durchführen von Bluttests |
CA2312913A1 (en) | 1997-12-12 | 1999-06-24 | Jeffrey C. Way | Compounds and methods for the inhibition of protein-protein interactions |
US6623981B2 (en) | 1998-01-27 | 2003-09-23 | Bristol-Myers Squibb Company | Detection of patients at risk for developing integrin antagonist/agonist mediated disease states |
EP1253928A4 (en) * | 2000-01-20 | 2005-06-15 | Hadasit Med Res Service | NEW HAPTOTACTIC PEPTIDES |
SE0001936D0 (sv) * | 2000-05-24 | 2000-05-24 | Phplate Stockholm Ab | New method and device |
AU2001262835A1 (en) * | 2000-05-24 | 2001-12-03 | Phplate Stockholm Ab | New method and device |
US8143210B2 (en) | 2002-02-14 | 2012-03-27 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for celiac sprue |
DK1572127T4 (da) | 2002-02-14 | 2014-11-24 | Univ Leland Stanford Junior | Enzymbehandling af fødevarer til cøliaki |
US20040005612A1 (en) * | 2002-05-14 | 2004-01-08 | Giudice Linda C. | Endometrial genes in endometrial disorders |
US7265093B2 (en) * | 2002-05-14 | 2007-09-04 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for Celiac Sprue |
CA2487247A1 (en) * | 2002-05-14 | 2003-11-27 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for celiac sprue |
US7462688B2 (en) * | 2002-05-14 | 2008-12-09 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides for diagnostic and therapeutic methods for celiac sprue |
CA2488558C (en) * | 2002-06-07 | 2013-08-20 | Dyax Corp. | Prevention and reduction of blood loss |
US7153829B2 (en) * | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
DK2386310T3 (en) * | 2002-08-28 | 2019-02-25 | Dyax Corp | Methods of preserving organs and tissues |
IL152609A0 (en) * | 2002-11-03 | 2003-06-24 | Hapto Biotech Inc | Liposomal compositions comprising haptotactic peptides and uses thereof |
ATE554392T1 (de) | 2002-11-20 | 2012-05-15 | Univ Leland Stanford Junior | Diagnoseverfahren für sprue/zöliakie |
US7579313B2 (en) * | 2003-11-18 | 2009-08-25 | The Board Of Trustees Of The Leland Stanford Junior University | Transglutaminase inhibitors and methods of use thereof |
US7629504B2 (en) * | 2003-12-22 | 2009-12-08 | Pioneer Hi-Bred International, Inc. | Bacillus thuringiensis cry9 nucleic acids |
US7235530B2 (en) * | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
US7807645B2 (en) * | 2005-09-23 | 2010-10-05 | The Regents Of The University Of California | Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment |
WO2007106746A2 (en) * | 2006-03-10 | 2007-09-20 | Dyax Corp. | Formulations for ecallantide |
WO2008115411A1 (en) * | 2007-03-16 | 2008-09-25 | The Board Of Trustees Of The Leland Stanford Junior University | Combination enzyme therapy for digestion of dietary gluten |
WO2010080833A1 (en) * | 2009-01-06 | 2010-07-15 | Dyax Corp. | Treatment of mucositis with kallikrein inhibitors |
SI2521568T1 (sl) * | 2010-01-06 | 2019-01-31 | Dyax Corp. | Proteini, ki vežejo plazemski kalikrein |
CN102791274B (zh) | 2010-02-22 | 2015-08-26 | 物产食品科技股份有限公司 | 上皮细胞间粘接增强剂和使用该增强剂的过敏的改善、治疗或预防剂 |
IL269565B2 (en) | 2011-01-06 | 2024-06-01 | Dyax Corp | KALLIKREIN PLASMA BINDING PROTEINS |
BR112016022318A2 (pt) | 2014-03-27 | 2017-10-31 | Dyax Corp | método, composição farmacêutica para uso no tratamento de doenças de retina e uso de um anticorpo |
JP7003354B2 (ja) | 2015-12-11 | 2022-03-04 | 武田薬品工業株式会社 | 遺伝性血管性浮腫の発作を治療するための血漿カリクレイン阻害薬およびその用途 |
US11986536B2 (en) | 2019-03-23 | 2024-05-21 | Ablevia Biotech Gmbh | Compound for the sequestration of undesirable antibodies in a patient |
EP3715376A1 (en) | 2019-03-23 | 2020-09-30 | Ablevia biotech GmbH | Compound for the prevention or treatment of myasthenia gravis |
EP3715374A1 (en) | 2019-03-23 | 2020-09-30 | Ablevia biotech GmbH | Compound for the sequestration of undesirable antibodies in a patient |
EP3715375A1 (en) | 2019-03-23 | 2020-09-30 | Ablevia biotech GmbH | Compound for the prevention or treatment of pre-eclampsia |
CA3192748A1 (en) | 2020-09-23 | 2022-03-31 | Oskar SMRZKA | Compound for increasing efficacy of viral vectors |
JP2023542389A (ja) | 2020-09-23 | 2023-10-06 | アブレヴィア バイオテック ゲーエムベーハー | 自己抗体で媒介される状態の予防又は治療のための化合物 |
MX2023003375A (es) | 2020-09-23 | 2023-03-31 | Ablevia Biotech Gmbh | Compuesto para aumentar la eficacia de la terapia de sustitucion del factor viii. |
TW202228784A (zh) | 2020-09-23 | 2022-08-01 | 奧地利商艾柏力維亞生技有限公司 | 用以於一患者中螯合非預期的抗peg抗體的化合物 |
EP4216990A1 (en) | 2020-09-23 | 2023-08-02 | Ablevia biotech GmbH | Compound for the sequestration of undesirable antibodies in a patient |
US20230381328A1 (en) | 2020-09-24 | 2023-11-30 | Ablevia Biotech Gmbh | Compound for the prevention or treatment of myasthenia gravis |
WO2023180502A1 (en) | 2022-03-24 | 2023-09-28 | Ablevia Biotech Gmbh | Compound for increasing efficacy of oncolytic viruses |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4455290A (en) * | 1981-04-02 | 1984-06-19 | Research Corporation | Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1 |
DE3364347D1 (en) * | 1982-04-09 | 1986-08-07 | Fujirebio Kk | Anti immune complex antibody and preparation thereof |
GB2161165A (en) * | 1984-06-12 | 1986-01-08 | Cambridge Patent Dev | Secondary antibodies |
US4820505A (en) * | 1985-04-04 | 1989-04-11 | Scripps Clinic And Research Foundation | Detection of activated platelets with antibodies to thrombospondin |
WO1990004634A1 (en) * | 1988-10-03 | 1990-05-03 | Scripps Clinic And Research Foundation | Monoclonal antibodies against receptor-induced binding sites |
-
1991
- 1991-02-12 US US07/654,839 patent/US5372933A/en not_active Expired - Lifetime
-
1992
- 1992-02-12 ES ES92906797T patent/ES2134799T3/es not_active Expired - Lifetime
- 1992-02-12 CA CA002103893A patent/CA2103893A1/en not_active Abandoned
- 1992-02-12 PT PT100122A patent/PT100122B/pt not_active IP Right Cessation
- 1992-02-12 DE DE69229911T patent/DE69229911T2/de not_active Expired - Fee Related
- 1992-02-12 JP JP50666892A patent/JP3315405B2/ja not_active Expired - Fee Related
- 1992-02-12 WO PCT/US1992/001163 patent/WO1992014150A1/en active IP Right Grant
- 1992-02-12 IE IE046292A patent/IE920462A1/en not_active IP Right Cessation
- 1992-02-12 AT AT92906797T patent/ATE184019T1/de not_active IP Right Cessation
- 1992-02-12 EP EP92906797A patent/EP0573545B1/en not_active Expired - Lifetime
- 1992-02-12 DK DK92906797T patent/DK0573545T3/da active
-
1999
- 1999-11-03 GR GR990402812T patent/GR3031720T3/el unknown
-
2002
- 2002-01-09 JP JP2002052356A patent/JP2002275196A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0573545A1 (en) | 1993-12-15 |
EP0573545A4 (en) | 1995-04-12 |
US5372933A (en) | 1994-12-13 |
IE920462A1 (en) | 1992-08-12 |
PT100122B (pt) | 1999-06-30 |
ATE184019T1 (de) | 1999-09-15 |
AU1415292A (en) | 1992-09-07 |
WO1992014150A1 (en) | 1992-08-20 |
JP3315405B2 (ja) | 2002-08-19 |
PT100122A (pt) | 1993-05-31 |
DE69229911D1 (de) | 1999-10-07 |
DE69229911T2 (de) | 2000-01-20 |
AU649800B2 (en) | 1994-06-02 |
JP2002275196A (ja) | 2002-09-25 |
DK0573545T3 (da) | 1999-12-13 |
EP0573545B1 (en) | 1999-09-01 |
CA2103893A1 (en) | 1992-08-13 |
ES2134799T3 (es) | 1999-10-16 |
JPH06506203A (ja) | 1994-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3031720T3 (en) | Monoclonal antibodies against receptor-induced binding sites. | |
ES8607564A1 (es) | Un metodo para determinar la presencia de un determinante antigenico de interleuquina-2-en una muestra. | |
EP0575546A4 (en) | Prad1 cyclin and its cdna | |
IL78444A0 (en) | Human gamma interferon-specific receptor protein,antibody against said protein,methods for obtaining said protein and said antibody and compositions containing said protein and antibody | |
EP0151239A3 (en) | Monoclonal antibodies specific to in vivo fragments derived from fibrinogen | |
GR82243B (el) | ||
YU49126B (sh) | Varijantni cd44-površinski proteini, dna-sekvence koje ih kodiraju i antitela protiv ovih proteina | |
GB8719587D0 (en) | Monoclonal antibodies & peptides | |
DE3268740D1 (en) | Rapid, quantitative peptide synthesis using mixed anhydrides | |
GB8608068D0 (en) | Monoclonal antibodies | |
EP0257778A3 (en) | Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas | |
TW272197B (el) | ||
GB2153364B (en) | Lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses | |
EP0167596A4 (en) | ANTI-IDIOTYPIC ANTIBODIES INDUCED BY SYNTHETIC POLYPEPTIDES. | |
IE860229L (en) | Monoclonal antibody | |
GR1002145B (en) | Monoclonal antibodies against receptor - induced binding sites | |
IL71702A (en) | Polypeptide growth factors,their preparation,antibodies thereto and compositions containing them | |
NZ222006A (en) | Monoclonal antibodies specific to omega-ifn | |
ATE180788T1 (de) | Polypeptide mit einer aktivität des menschlichen dopaminergischen rezeptors, deren kodierende nukleinsäuresequenzen und verwendung dieser polypeptide | |
FI101808B1 (fi) | Monoklonaaliset vasta-aineet reseptori-indusoituja sitoutumiskohtia vastaan | |
NZ228194A (en) | Monoclonal antibodies which bind to the n-terminal peptide sequence of the betasubunit of human haemoglobiin | |
EP0292302A3 (en) | Human splenin | |
IL91034A (en) | Monoclonal antibodies specific to glucosylated n-terminal peptide sequence in hemoglobin atc | |
AU8333082A (en) | Rapid quantitative peptide synthesis using mixed anhydrides | |
ES1009403U (es) | Unos tirantes-hombrera graduables en altura, para mochilas y similares. |